AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies
DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the specialty pharmaceutical industry, proudly announces its role as Gold Sponsor of the World Orphan Drug Congress Europe (WODC), 22-25 October 2024, Barcelona, Spain.
To read more, click here